The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

e-Learning
CMRP Information Systems and Data Management Course
e-Learning
CMRP Inventory and Distribution Management Course
e-Learning
CMRP Procurement and Product Value Analysis Course
e-Learning
CMRP Strategic Planning, Leadership, and Compliance Course
Webcast
Webcast: A New Hospital Economic Index: Join on the Ground Level
This short webcast will give you a brief overview of the current ISM® Report On Business, share details surrounding the development of the new
Webcast
UDI: Value Beyond Compliance
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the val